Get Live Data

The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Renalytix Plc Share Price
  4. Renalytix Plc Share Regulatory News
  5. Total Voting Rights

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Renalytix Plc Information

Share Price Information for Renalytix Plc (RENX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.50
Bid: 19.00
Ask: 20.00
Change: -2.00 (-9.30%)
Spread: 1.00 (5.263%)
Open: 20.00
High: 20.00
Low: 19.50
Prev. Close: 21.50
RENX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

31 Jul 2020 16:31

RNS Number : 8003U
Renalytix AI PLC
31 July 2020
 

 

 

Renalytix AI plc

(the "Company") 

 

Total Voting Rights

 

For the purposes of DTR5.6.1R of the Transparency Directive, the Company notifies the market of the following:

 

As of 31 July 2020, the Company's issued and fully paid share capital consists of 72,029,634 ordinary shares with a nominal value of £0.0025 each ("Ordinary Shares"), with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. The total number of voting rights in the Company is therefore 72,029,634.

 

The above figure of 72,029,634 should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

 

For further information, please contact:

 

Renalytix AI plc 

www.renalytixai.com

James McCullough, CEO

Via Walbrook PR

Stifel (Nominated Adviser)

Tel: 020 7710 7600

Alex Price / Nicholas Moore

Walbrook PR Limited

Tel: 020 7933 8780 or renalytix@walbrookpr.com

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRFFLFXBDLEBBL
12345678910
Date   Source Headline
3rd Jan 20207:00 amRNSCMS Pricing Determination becomes effective
3rd Dec 20197:00 amRNSMedicare sets US national price for KidneyIntelX
21st Nov 20197:00 amRNSGrant of Options
19th Nov 20197:00 amRNSRenalytixAI attending City Event for Kidney Health
17th Oct 20197:00 amRNSPartnership with CDPHP on KidneyIntelX
14th Oct 20197:00 amRNSBoard appointment
1st Oct 20197:00 amRNSUS CPT® reimbursement code effective
30th Sep 20194:37 pmRNSResult of AGM
30th Sep 20198:00 amRNSUpdate on non-executive director appointment
30th Sep 20197:00 amRNSPreliminary Medicare Pricing Determination
6th Sep 20194:00 pmRNSPosting of Annual Report & Accounts &Notice of AGM
3rd Sep 20197:00 amRNSFinal Results
20th Aug 20197:00 amRNSNotice of Results
6th Aug 20197:00 amRNSExpansion of Chronic Kidney Disease Advisory Board
31st Jul 20194:30 pmRNSTotal Voting Rights
29th Jul 20197:00 amRNSThomas McLain Appointed as President and CCO
23rd Jul 20196:23 pmRNSResult of Placing & Total Voting Rights
23rd Jul 20197:01 amRNSProposed Placing to raise £12.0m (c.US$15.0m)
12th Jul 20197:00 amRNSUS Exec Order on Advancing American Kidney Health
9th Jul 20197:00 amRNSPositive Interim Results for Validation Study
8th Jul 20197:00 amRNSFractalDx Positive Results Published in JASN
1st Jul 20197:00 amRNSUS CPT® Code Granted for KidneyIntelX(TM)
7th Jun 20197:00 amRNSPositive results from FractalDx study published
4th Jun 20197:00 amRNSKidneyIntelX commercial scale production milestone
28th May 20197:00 amRNSCLIA Certificate Number issued for Renalytix Lab
21st May 20197:00 amRNSExpansion of FractalDx core investigator group
7th May 20197:00 amRNSUniversity Medical Center Groningen collaboration
2nd May 20192:05 pmRNSSecond Price Monitoring Extn
2nd May 20192:00 pmRNSPrice Monitoring Extension
2nd May 20197:00 amRNSFDA grants Breakthrough Device designation
26th Apr 20196:20 pmRNSAcquisition of further interest in Renalytix AI
26th Apr 20195:42 pmRNSDirector/PDMR Shareholding
2nd Apr 201912:55 pmRNSHolding(s) in Company
1st Apr 20197:00 amRNSPublication of confirmation study results
25th Mar 20197:00 amRNSHalf-year Report
22nd Mar 20197:00 amRNSRenalytixAI Forms Core Investigator Group
12th Mar 20197:00 amRNSInvestor briefing
14th Feb 20197:00 amRNSAppointment of Nomad and Joint Broker
13th Feb 20197:00 amRNSJoint venture partnership agreement with AKESOgen
6th Feb 20197:00 amRNSRenalytixAI Expands Leadership Team
23rd Jan 20197:00 amRNSInitiates Clinical Validation Study
21st Jan 20197:00 amRNSClarification re. lock-up restrictions
2nd Jan 20197:00 amRNSExercise of Option for Exclusive License
20th Dec 20185:20 pmRNSDirector/PDMR Shareholding
20th Dec 20187:01 amRNSPlanned appointment of joint broker & of NOMAD
19th Dec 20186:28 pmRNSDirector Dealing
17th Dec 20181:30 pmRNSHolding(s) in Company
9th Nov 201810:30 amRNSHolding(s) in Company
8th Nov 20184:50 pmRNSHolding(s) in Company
8th Nov 20187:00 amRNSDirector/PDMR Shareholding
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.